Granite Point Capital Management’s AngioDynamics ANGO Stock Holding History

Granite Point Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-20,000	Closed	-$356K	–	100
2015 Q1	$356K	Buy	+20,000	New	+$372K	0.13%	86
2014 Q3	–	Sell	-65,000	Closed	-$1.06M	–	81
2014 Q2	$1.06M	Buy	65,000 +7,400	+13%	+$107K	0.73%	28
2014 Q1	$907K	Buy	57,600 +47,600	+476%	+$776K	0.65%	51
2013 Q4	$172K	Buy	+10,000	New	+$154K	0.03%	98

Other funds holding ANGO

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMA

Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Granite Point Capital Management's ANGO Position: Q2 2015 in Review

Granite Point Capital Management sold out of AngioDynamics (ANGO) in Q2 2015, closing a stake of 20,000 shares — an estimated $356K sold.

Granite Point Capital Management first reported a position in ANGO in Q4 2013 and held it in 4 quarters. The position peaked at $1.06M in Q2 2014. 116 funds tracked by Wall St. Rank hold ANGO as of Q2 2015.

Granite Point Capital Management reported no remaining AngioDynamics position as of Q2 2015 after selling out during the quarter.
Granite Point Capital Management sold 20,000 AngioDynamics shares in Q2 2015, an estimated $356K.
Granite Point Capital Management first reported a position in AngioDynamics in Q4 2013 and held it in 4 quarters.
Granite Point Capital Management's AngioDynamics position peaked at $1.06M in Q2 2014.
116 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2015.

Based on Granite Point Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.